What did the researchers do?
The researchers established the National Epidemiology Donor Database to analyse data from all blood donations to Canadian Blood Services for the period 2006-2009. All donations were tested for transmissible diseases following standard testing procedures to detect HIV, hepatitis C and hepatitis B DNA or RNA and antibodies. All blood donors who tested positive for HIV, hepatitis B or hepatitis C and had a previous blood donation that was negative were considered to be new infections. The researchers used a published method to estimate the incidence rates and residual risk. Incidence rates were based on data from donors who had made at least two donations within three years.
What did the researchers find?
The window-period for HIV and hepatitis C is less than two weeks, and about a month for hepatitis B.
The residual risk was 1 in 8 million donations for HIV, 1 in 6.7 million donations for hepatitis C and 1 in 1.7 million donations for hepatitis B.
How can you use this research?
The residual risk of infection estimates are used by physicians to counsel their patients about the risks of transfusion. It is also used by Canadian Blood Services, and other blood suppliers, for policy formulation around blood donation and testing. It can also be used to inform donors as to why answering blood donation questions is important for the safety of the blood supply.
What is the risk of a transfusiontransmitted infection?
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In brief…
The chance of a blood recipient becoming infected with HIV, hepatitis C or hepatitis B from a blood transfusion is extremely low. However, because blood is derived from people and because tests will never be 100 per cent reliable, the risk will never be zero. 
